AP337A - Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. - Google Patents
Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. Download PDFInfo
- Publication number
- AP337A AP337A APAP/P/1992/000352A AP9200352A AP337A AP 337 A AP337 A AP 337A AP 9200352 A AP9200352 A AP 9200352A AP 337 A AP337 A AP 337A
- Authority
- AP
- ARIPO
- Prior art keywords
- salts
- inhibitors
- salt
- gastric acid
- acid secretion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101918A GB9101918D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
| GB919101919A GB9101919D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9200352A0 AP9200352A0 (en) | 1992-01-31 |
| AP337A true AP337A (en) | 1994-04-08 |
Family
ID=26298350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1992/000352A AP337A (en) | 1991-01-29 | 1992-01-27 | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0569396A1 (fr) |
| JP (1) | JPH06504541A (fr) |
| CN (1) | CN1064268A (fr) |
| AP (1) | AP337A (fr) |
| AU (1) | AU652028B2 (fr) |
| CA (1) | CA2099117A1 (fr) |
| CZ (1) | CZ153293A3 (fr) |
| FI (1) | FI933376A0 (fr) |
| HU (1) | HUT67609A (fr) |
| IE (1) | IE920267A1 (fr) |
| IL (1) | IL100791A0 (fr) |
| MA (1) | MA22401A1 (fr) |
| MX (1) | MX9200338A (fr) |
| NO (1) | NO932722L (fr) |
| NZ (1) | NZ241408A (fr) |
| PT (1) | PT100056A (fr) |
| SK (1) | SK70993A3 (fr) |
| WO (1) | WO1992012969A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| CA2467652A1 (fr) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Agents utiles pour le traitement des troubles des voies aeriennes |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| JP4634144B2 (ja) | 2002-08-01 | 2011-02-16 | ニコックス エスエー | ニトロソ化プロトンポンプ阻害剤、組成物および使用方法 |
| EP1974730A1 (fr) | 2003-11-03 | 2008-10-01 | AstraZeneca AB | Dérivés d'imidazo[1,2-a]pyridine pour l'utilisation dans le traitement des troubles du sommeil provoqués par un reflux gastro-oesophagien silencieux |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0330485A1 (fr) * | 1988-02-25 | 1989-08-30 | SmithKline Beecham Intercredit B.V. | Dérivés des 4-amino-3-acylquinoléines, et leur utilisation pour l'inhibition de la sécrétion gastrique |
-
1992
- 1992-01-27 FI FI933376A patent/FI933376A0/fi unknown
- 1992-01-27 CA CA002099117A patent/CA2099117A1/fr not_active Abandoned
- 1992-01-27 HU HU9302201A patent/HUT67609A/hu unknown
- 1992-01-27 MA MA22687A patent/MA22401A1/fr unknown
- 1992-01-27 AP APAP/P/1992/000352A patent/AP337A/en active
- 1992-01-27 SK SK709-93A patent/SK70993A3/sk unknown
- 1992-01-27 MX MX9200338A patent/MX9200338A/es unknown
- 1992-01-27 NZ NZ241408A patent/NZ241408A/en unknown
- 1992-01-27 JP JP4503051A patent/JPH06504541A/ja active Pending
- 1992-01-27 WO PCT/EP1992/000200 patent/WO1992012969A1/fr not_active Ceased
- 1992-01-27 AU AU11799/92A patent/AU652028B2/en not_active Ceased
- 1992-01-27 EP EP92903019A patent/EP0569396A1/fr not_active Withdrawn
- 1992-01-27 CZ CZ931532A patent/CZ153293A3/cs unknown
- 1992-01-28 IE IE026792A patent/IE920267A1/en unknown
- 1992-01-28 IL IL100791A patent/IL100791A0/xx unknown
- 1992-01-28 CN CN92101029A patent/CN1064268A/zh active Pending
- 1992-01-28 PT PT100056A patent/PT100056A/pt not_active Application Discontinuation
-
1993
- 1993-07-28 NO NO93932722A patent/NO932722L/no unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0330485A1 (fr) * | 1988-02-25 | 1989-08-30 | SmithKline Beecham Intercredit B.V. | Dérivés des 4-amino-3-acylquinoléines, et leur utilisation pour l'inhibition de la sécrétion gastrique |
Also Published As
| Publication number | Publication date |
|---|---|
| FI933376L (fi) | 1993-07-28 |
| JPH06504541A (ja) | 1994-05-26 |
| FI933376A7 (fi) | 1993-07-28 |
| FI933376A0 (fi) | 1993-07-28 |
| IL100791A0 (en) | 1992-09-06 |
| NO932722D0 (no) | 1993-07-28 |
| AU652028B2 (en) | 1994-08-11 |
| PT100056A (pt) | 1993-03-31 |
| CN1064268A (zh) | 1992-09-09 |
| MA22401A1 (fr) | 1992-10-01 |
| MX9200338A (es) | 1992-12-01 |
| CA2099117A1 (fr) | 1992-07-30 |
| NO932722L (no) | 1993-07-28 |
| SK70993A3 (en) | 1994-01-12 |
| AU1179992A (en) | 1992-08-27 |
| NZ241408A (en) | 1994-05-26 |
| IE920267A1 (en) | 1992-07-29 |
| EP0569396A1 (fr) | 1993-11-18 |
| HU9302201D0 (en) | 1993-10-28 |
| CZ153293A3 (en) | 1993-12-15 |
| HUT67609A (en) | 1995-04-28 |
| AP9200352A0 (en) | 1992-01-31 |
| WO1992012969A1 (fr) | 1992-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3447292B2 (ja) | イミダゾピリジン及び胃腸の疾病の治療のためのその使用 | |
| AP337A (en) | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. | |
| KR100704152B1 (ko) | ＮＦ-κＢ 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제 | |
| JP2502343B2 (ja) | 薬学的に活性な置換ベンズアミド | |
| CN1127470C (zh) | 新型苯并环己酮或苯并吡喃酮衍生物及其制备方法 | |
| US5045541A (en) | Fused pyridazine compounds and their pharmaceutical use | |
| EP3216791B1 (fr) | Substance polymorphe de chlorhydrate de yonkenafil, son procédé de préparation, composition à base de ladite substance et utilisation deladite substance | |
| EP1097924B1 (fr) | Dérivés de la 4-hydroxy-4-phenylpiperidine ayant une activité agoniste opioide et médicaments les contenant | |
| EP0104614A1 (fr) | Dérivés du phénylpipérazine et leur procédé de préparation | |
| JP2974351B2 (ja) | プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート | |
| JPWO2002030896A1 (ja) | ２，２−ジフェニルブタンアミド誘導体及びこれを含有する医薬 | |
| EP0146155B1 (fr) | Dérivé d'un éther de n-propanolamine | |
| WO2023154338A1 (fr) | Formes solides d'un inhibiteur de parp14 | |
| JPS6130588A (ja) | ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤 | |
| JPH069402A (ja) | 抗潰瘍剤 | |
| WO1990004590A1 (fr) | Derives de benzothiadiazepine | |
| KR880001281B1 (ko) | 9,10-치환된 2-메시틸이미노-3-알킬-3,4,6,7-테트라하이드로-2H-피리미도(6,1-a)이소퀴놀린-4-온의 제조방법 | |
| WO2021249324A1 (fr) | Composé d'alcényle pyrimidine, procédé de préparation associé et son application | |
| JP2000038382A (ja) | 新規ベンゾフラノン誘導体及びその製造方法 | |
| JPH0517442A (ja) | ピペリジン誘導体 | |
| JPH01216980A (ja) | アルキル―ピペラジニル―５，６―アルキレンピリミジン類 | |
| JPWO2001000588A1 (ja) | ベンズイミダゾール化合物及びこれを含む医薬 | |
| JPS60105652A (ja) | Ｎ‐（４‐アセチルアミノフエナシル）アミン誘導体およびこれを含む治療用組成物ならびにこの誘導体の製造方法 | |
| HUT77949A (hu) | Kinolinszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HU198390B (en) | Process for producing pharmaceutical compositions containing 3-carboxy-azetidine or derivatives |